文献速递心脏核医学

68Ga-NODAGA-RGD PET/CT 评估大动脉粥样硬化血管新生与临床动脉粥样硬化性心血管病的关联

Imaging angiogenesis in atherosclerosis in large arteries with 68Ga-NODAGA-RGD PET/CT: relationship with clinical atherosclerotic cardiovascular disease.
PubMed 文献 · EJNMMI Res · 2021-08-14

回顾性分析44例接受68Ga-NODAGA-RGD PET/CT患者的动脉壁示踪剂摄取,发现既往有临床动脉粥样硬化性心血管病者摄取显著更高,且与心脑血管事件、BMI、斑块负荷及高胆固醇血症相关,提示该显像有望作为粥样硬化疾病活动性的无创标志物。

要点

  • 既往有临床动脉粥样硬化性心血管病者动脉壁68Ga-NODAGA-RGD摄取显著更高。
  • 动脉壁摄取与既往心脑血管事件、BMI、斑块负荷和高胆固醇血症相关。
  • 68Ga-NODAGA-RGD PET/CT有望无创反映斑块内血管新生和疾病活动性。

核心结论

  • 68Ga-NODAGA-RGD PET/CT有望作为动脉粥样硬化疾病活动性的无创标志物,提供斑块内血管新生信息。

研究设计与样本

  • 回顾性分析44例接受68Ga-NODAGA-RGD PET/CT扫描患者的资料。
  • 对大动脉血管壁示踪剂摄取采用经血池校正的靶本比进行半定量分析。
  • 将示踪剂摄取与临床记录的动脉粥样硬化性心血管病、心血管危险因素及钙化斑块负荷进行比较。
  • 统计学方法包括Mann-Whitney U检验、Pearson相关和Spearman相关。

主要发现

  • 既往有临床记录动脉粥样硬化性心血管病患者的68Ga-NODAGA-RGD动脉摄取显著更高,平均TBR为2.44(2.03-2.55)对1.81(1.56-1.96),p=0.001。
  • 动脉摄取与既往心血管或脑血管事件显著相关(r=0.33,p=0.027)。
  • 动脉摄取与BMI显著相关(ρ=0.38,p=0.01)。
  • 动脉摄取与斑块负荷显著相关(ρ=0.31,p=0.04)。
  • 动脉摄取与高胆固醇血症显著相关(r=0.31,p=0.04)。

临床怎么用

  • 对动脉粥样硬化患者,可考虑用68Ga-NODAGA-RGD PET/CT无创评估斑块内αvβ3整合素表达相关的血管新生和疾病活动性。

局限性

  • 原文为回顾性分析,样本量44例,结论需进一步前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Integrin alpha-V-beta-3 (αvβ3) pathway is involved in intraplaque angiogenesis and inflammation and represents a promising target for molecular imaging in cardiovascular diseases such as atherosclerosis. The aim of this study was to assess the clinical correlates of arterial wall accumulation of 68Ga-NODAGA-RGD, a specific αvβ3 integrin ligand for PET. MATERIALS AND METHODS: The data of 44 patients who underwent 68Ga-NODAGA-RGD PET/CT scans were retrospectively analyzed. Tracer accumulation in the vessel wall of major arteries was analyzed semi-quantitatively by blood-pool-corrected target-to-background ratios. Tracer uptake was compared with clinically documented atherosclerotic cardiovascular disease, cardiovascular risk factors and calcified plaque burden. Data were compared using the Mann-Whitney U test, Pearson correlation and Spearman correlation. RESULTS: 68Ga-NODAGA-RGD arterial uptake was significantly higher in patients with previous clinically documented atherosclerotic cardiovascular disease (mean TBR 2.44 [2.03-2.55] vs. 1.81 [1.56-1.96], p = 0.001) and showed a significant correlation with prior cardiovascular or cerebrovascular event (r = 0.33, p = 0.027), BMI (ρ = 0.38, p = 0.01), plaque burden (ρ = 0.31, p = 0.04) and hypercholesterolemia (r = 0.31, p = 0.04). CONCLUSIONS: 68Ga-NODAGA-RGD holds promise as a non-invasive marker of disease activity in atherosclerosis, providing information about intraplaque angiogenesis.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Dietz M, Kamani CH, Deshayes E, et al. Imaging angiogenesis in atherosclerosis in large arteries with 68Ga-NODAGA-RGD PET/CT: relationship with clinical atherosclerotic cardiovascular disease. EJNMMI Res. 2021. PMID: 34390409. doi:10.1186/s13550-021-00815-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。